Skip to Main Content

Advertisement

Close

AACR Journals
For Authors
About Us
Article Collections
COVID-19
Webinars

header search

search input Search input auto suggest

Search

Advanced Search

Menu

About
Articles
For Authors
Alerts
News
COVID-19
Webinars

Skip Nav Destination

Issues

Select Year

Issue

Volume 1, Issue 11

1 November 1995

Front Matter
Table of Contents
Back Matter
Editorial Board

ISSN 1078-0432

EISSN 1557-3265

Issue Sections

Minireview
Advances in Brief
Research Articles

Minireview

Preclinical studies of water-insoluble camptothecin congeners: cytotoxicity, development of resistance, and combination treatments.

P Pantazis

Advances in Brief

Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions.

H Tahara; H Kuniyasu; H Yokozaki; W Yasui; J W Shay; T Ide; E Tahara

Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin.

W Debinski; N I Obiri; S K Powers; I Pastan; R K Puri

Research Articles

Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42/6.

D Brooks; C Taylor; B Dos Santos; H Linden; A Houghton; T T Hecht; S Kornfeld; R Taetle

Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancer.

L Vahdat; G Raptis; D Fennelly; N Hamilton; L Reich; A Tiersten; M Harrison; C Hudis; M Moore; T J Yao

Clinical pharmacokinetic and pharmacodynamic studies with the nonclassical antifolate thymidylate synthase inhibitor 3, 4-dihydro-2-amino-6-methyl-4-oxo-5-(4-pyridylthio)-quinazolone dihydrochloride (AG337) given by 24-hour continuous intravenous infusion.

I Rafi; G A Taylor; J A Calvete; A V Boddy; K Balmanno; N Bailey; M Lind; A H Calvert; S Webber; R C Jackson

Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.

K A Foon; A R Oseroff; L Vaickus; S J Greenberg; D Russell; Z Bernstein; S Pincus; H Köhler; B K Seon; E Tahaoglu

p53 nuclear protein expression is an independent prognostic marker in clinically localized prostate cancer patients undergoing radical prostatectomy.

J J Bauer; I A Sesterhenn; K F Mostofi; D G McLeod; S Srivastava; J W Moul

Expression of the multidrug resistance-associated protein (MRP) gene in human cancers.

K Nooter; A M Westerman; M J Flens; G J Zaman; R J Scheper; K E van Wingerden; H Burger; R Oostrum; T Boersma; P Sonneveld

Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model.

N I Goldstein; M Prewett; K Zuklys; P Rockwell; J Mendelsohn

Monocyte-mediated lysis of acute myeloid leukemia cells in the presence of the bispecific antibody 251 x 22 (anti-CD33 x anti-CD64).

J Chen; J H Zhou; E D Ball

Alterations in T cell receptor and signal transduction molecules in melanoma patients.

A H Zea; B D Curti; D L Longo; W G Alvord; S L Strobl; H Mizoguchi; S P Creekmore; J J O'Shea; G C Powers; W J Urba

In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.

A Guglielmi; C Aschele; A Mori; C Baldo; P Russo; D Debernardis; M Valenti; S Bruno; M Taverna; R Rosso

Effects of 9-aminocamptothecin on newly synthesized DNA in patient bone marrow samples.

F Geoffroy; W Dahut; C H Takimoto; J L Grem

Involvement of human interleukin 6 in experimental cachexia induced by a human uterine cervical carcinoma xenograft.

S Tamura; K F Ouchi; K Mori; M Endo; T Matsumoto; H Eda; Y Tanaka; H Ishitsuka; H Tokita; K Yamaguchi

Retroviral transfer of a bacterial alkyltransferase gene into murine bone marrow protects against chloroethylnitrosourea cytotoxicity.

L C Harris; U K Marathi; C C Edwards; P J Houghton; D K Srivastava; E F Vanin; B P Sorrentino; T P Brent

Preclinical toxicity of liposome-incorporated annamycin: selective bone marrow toxicity with lack of cardiotoxicity.

Y Zou; W Priebe; L C Stephens; R Perez-Soler

Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.

G Gasparini; P Bevilacqua; E Bonoldi; A Testolin; A Galassi; P Verderio; P Boracchi; R B Guglielmi; F Pezzella

Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer.

A Latil; O Cussenot; G Fournier; J C Baron; R Lidereau

Expression of topoisomerase II, bcl-2, and p53 in three human brain tumor cell lines and their possible relationship to intrinsic resistance to etoposide.

C E Herzog; L A Zwelling; A McWatters; E S Kleinerman

Effects of modulators of protein kinases on taxol-induced apoptosis of human leukemic cells possessing disparate levels of p26BCL-2 protein.

V Ponnathpur; A M Ibrado; J C Reed; S Ray; Y Huang; S Self; G Bullock; A Nawabi; K Bhalla

Pretreatment p53 protein expression correlates with decreased survival in patients with end-stage head and neck cancer.

E R Sauter; J A Ridge; S Litwin; C J Langer

Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression.

H Friess; Y Yamanaka; M S Kobrin; D A Do; M W Büchler; M Korc

Elevated levels of 2',5'-linked oligoadenylate-dependent ribonuclease L occur as an early event in colorectal tumorigenesis.

L Wang; A Zhou; S Vasavada; B Dong; H Nie; J M Church; B R Williams; S Banerjee; R H Silverman

Overexpression of insulin receptor substrate 1 (IRS-1) in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation.

E Surmacz; J L Burgaud

Advertisement

Email alerts

Online First Alert

eTOC Alert

Latest
Most Read
Most Cited

[18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

Characterization of Cell-free DNA Size Distribution in Osteosarcoma Patients

Single-cell transcriptomics reveals immune reconstitution in R/R T-ALL/LBL patients with donor-derived CD7 CAR-T therapy

The oral PI3Kδ inhibitor linperlisib for the treatment of relapsed and/or refractory follicular lymphoma: A phase 2, single-arm, open-label clinical trial

Issues
Online First
Collections

News
Twitter

Online ISSN 1557-3265
Print ISSN 1078-0432

AACR Journals

Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers, & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics

Info for Advertisers
Info for Librarians
Privacy Policy

Twitter
LinkedIn
Facebook
Youtube

Copyright © 2022 by the American Association for Cancer Research.

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.

Accept